Red-emitting FIT-PNAs: "On site" detection of RNA biomarkers in fresh human cancer tissues.


Journal

Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289

Informations de publication

Date de publication:
15 Jul 2019
Historique:
received: 22 01 2019
revised: 15 04 2019
accepted: 29 04 2019
pubmed: 24 5 2019
medline: 20 11 2019
entrez: 24 5 2019
Statut: ppublish

Résumé

To date, there are limited approaches for the direct and rapid visualization (on site) of tumor tissues for pathological assessment and for aiding cytoreductive surgery. Herein, we have designed FIT-PNAs (forced-intercalation-peptide nucleic acids) to detect two RNA cancer biomarkers. Firstly, a lncRNA (long noncoding RNA) termed CCAT1, has been shown as an oncogenic lncRNA over-expressed in a variety of cancers. The latter, an mRNA termed KRT20, has been shown to be over-expressed in metastases originating from colorectal cancer (CRC). To these FIT-PNAs, we have introduced the bis-quinoline (BisQ) cyanine dye that emits light in the red region (605-610 nm) of the visible spectrum. Most strikingly, spraying fresh human tissue taken from patients during cytoreductive surgery for peritoneal metastasis of colon cancer with an aqueous solution of CCAT1 FIT-PNA results in bright fluorescence in a matter of minutes. In fresh healthy tissue (from bariatric surgeries), no appreciable fluorescence is detected. In addition, a non-targeted FIT-PNA shows no fluorescent signal after spraying this FIT-PNA on fresh tumor tissue emphasizing the specificity of these molecular sensors. This study is the first to show on-site direct and immediate visualization of an RNA cancer biomarker on fresh human cancer tissues by topical application (spraying) of a molecular sensor.

Identifiants

pubmed: 31121464
pii: S0956-5663(19)30347-1
doi: 10.1016/j.bios.2019.04.056
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
CCAT1 long noncoding RNA, human 0
Intercalating Agents 0
KRT20 protein, human 0
Keratin-20 0
Peptide Nucleic Acids 0
RNA, Long Noncoding 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271-278

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Dina Hashoul (D)

School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Hadassah Ein-Kerem, Jerusalem, 91120, Israel.

Rachel Shapira (R)

Department of General and Oncological Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel.

Maria Falchenko (M)

School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Hadassah Ein-Kerem, Jerusalem, 91120, Israel.

Odelia Tepper (O)

School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Hadassah Ein-Kerem, Jerusalem, 91120, Israel.

Vera Paviov (V)

Department of General and Oncological Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel.

Aviram Nissan (A)

Department of General and Oncological Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel. Electronic address: Aviram.Nissan@sheba.health.gov.il.

Eylon Yavin (E)

School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Hadassah Ein-Kerem, Jerusalem, 91120, Israel. Electronic address: eylony@ekmd.huji.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH